Drug Information Association Logo

DIA Announces New Clinical Safety and Pharmacovigilance Certificate Program

Horsham, PA, USA — Dec 11, 2009

The Drug Information Association (DIA) today announced the creation of its Clinical Safety and Pharmacovigilance Certificate Program.

This is the third program developed by DIA, which also offers a certificate program in clinical research and project management. DIA’s Clinical Safety and Pharmacovigilance Certificate Program focuses on topics related to:

  • Pre- and postmarketing clinical safety and pharmacovigilance
  • Risk management strategies  
  • Safety inspections 
  • Signal detection and data mining
  • Medical approaches in diagnosis and management of ADRs 
  • Drug safety surveillance and epidemiology

DIA is an established, recognized training authority for professionals who work in all areas of the biopharmaceutical industry. Its certificate program features world-class faculty and small interactive courses that include case studies, simulations, and other activities that expand learning, while offering continuing education credits.

“Our new Clinical Safety and Pharmacovigilance Certificate Program addresses the practical and theoretical aspects of the conduct of pharmacovigilance, with emphasis on the concepts and themes that create effective processes, as well as the basic tenets of global regulatory compliance with safety principles,” says DIA Worldwide Executive Director Paul Pomerantz, MBA, CAE.

Enrollment is free. Fees for each course vary based on length. For more information, visit the Clinical Safety and Pharmacovigilance Certificate Program page or contact Laura Parker at 215-442-6101 or Laura.Parker@diahome.org.

 

 

 

 

###

ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Penn., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org.